Fig. 5
From: Advances in molecular pathology and therapy of non-small cell lung cancer
An algorithm of evidence-based management for stage I-III NSCLC. This flowchart comprehensively illustrates the treatment options for early-stage lung cancer, maintaining flexibility through the use of dashed lines to indicate alternative choices. However, this illustration focuses primarily on multi-level drug options and does not detail more technical treatment options such as radiotherapy and surgery, which may be more crucial for certain patients. For neoadjuvant regimens, particularly the combination of chemotherapy with ICIs, the recommendation level remains consistent across different options
